	Liver Transplantation for Combined Hepatocellular-Cholangiocarcinoma: A Retrospective Registry-Based Study Using the Korean Organ Transplant Registry (KOTRY). Ann Transplant Kim SH, Hwang S, Kim BW, Joo DJ, Lee KW, Choi GS, Ryu JH, Kim DS, Choi D, Cho JY, You YK, Choi D, Kim TS, Park P. PMID: 41399117 [PubMed - indexed for MEDLINE]
	Basic research on quercetin in liver cancer: Progress and perspectives. Medicine (Baltimore) Liu B, Yu Y, Wang R, Wu Y, Sun K. PMID: 41398772 [PubMed - indexed for MEDLINE]
	Prognostic and immunological implications of sialylation-associated gene signatures in hepatocellular carcinoma. Ann Med Wang GQ, Du K, Wang YP. PMID: 41398172 [PubMed - indexed for MEDLINE]
	The "silent assassin" of the liver: angiosarcoma with portal hypertension. Med Ultrason Zhang X, Qu N, Cao X. PMID: 41397175 [PubMed - indexed for MEDLINE]
	Concomitant medication use and clinical outcome in hepatocellular carcinoma treated with immune-based therapy: a multicenter analysis. Front Immunol Yi JZ, Xu J, Zeng JZ, Song YJ, Zhang YN, Huang CM, Li L, Ding K, Zhu ZJ, Yuan DZ, Fan YW, Ning SF, Liu X, Zhang JZ, You YF, Zhou Q, Song HJ, Tan GJ, Wu XT, Guo RP, Chen MS, Lyu N, Zhao M. PMID: 41394828 [PubMed - indexed for MEDLINE]
	Predictive value of peripheral blood CD4(+) T and NK cells on efficacy and long-term survival in advanced HCC patients receiving immunotherapy. Front Immunol Pan Z, Song S, An Y, Guan L, Liu H, Li W. PMID: 41394802 [PubMed - indexed for MEDLINE]
	Adrenal crisis occurring after the application of immune checkpoint inhibitors in a hepatitis B - related hepatocellular carcinoma patient: case report and literature review. Front Immunol Guo Y, Zhu Q, Ren W, Li F. PMID: 41394799 [PubMed - indexed for MEDLINE]
	Real-World Survival Outcomes of Atezolizumab and Bevacizumab in Unresectable Hepatocellular Carcinoma Patients With Hepatitis B Virus Infection: A Hospital-Based Cohort Study. Cancer Control Dung NT, Binh NH, Quang BV, Hien TT, Phuong PC, Thang VH. PMID: 41388811 [PubMed - indexed for MEDLINE]
	Glucagon-Like Peptide-1 Receptor Agonists and Hepatocellular Carcinoma Prevention: A Meta-Analysis and Clinical Decision Framework. Cancer Med Dalbeni A, Vicardi M, Natola LA, Cattazzo F, Auriemma A, Lombardi R, Cinque F, Dalle Carbonare L, Mantovani A, Sacerdoti D. PMID: 41388641 [PubMed - indexed for MEDLINE]
	Getting to Implementation: applying data-driven implementation strategies to improve guideline concordant surveillance for hepatocellular carcinoma. Implement Sci Yakovchenko V, Kang C, Neely B, Lamorte C, McCurdy H, Scott D, Nobbe A, Robins G, Ekanem NR, Merante M, Gibson S, Spoutz P, Chia L, Gonzalez RI, Chinman MJ, Ross D, Chartier M, Beste LA, Bajaj JS, Taddei T, Morgan TR, Rogal SS. PMID: 41388318 [PubMed - indexed for MEDLINE]
	The alternative splicing landscape of hepatocellular carcinoma and its potential for HCC detection. Hepatol Commun Hershberger CE, Daniels NJ, Patterson WM, Rotroff DM. PMID: 41385729 [PubMed - indexed for MEDLINE]
	MRI-Based Score to Predict Retreatment Response for Viable Hepatocellular Carcinomas After Transarterial Chemoembolization. Liver Int Wang W, Zhang X, Yu Y, Feng F, Cai W, Zhou S, Zhang S, Li B, Xia T, Ju S, Wang YC. PMID: 41384562 [PubMed - indexed for MEDLINE]
	Preoperative TACE with PD-1 inhibitors and TKIs in beyond "up-to-seven" hepatocellular carcinoma: a propensity score matched analysis. Front Immunol Zhong D, Liang Y, Chen Y, Su Y, Yang Q, Yan H, Huang X, Wang M. PMID: 41383585 [PubMed - indexed for MEDLINE]
	Safety and efficacy of percutaneous ultrasound-guided radiofrequency ablation for patients with colorectal liver metastases â‰¥5 lesions. Int J Hyperthermia Zhang ZY, Wang H, Wang S, Wu W, Yan K, Wang ZH, Yang W. PMID: 41381373 [PubMed - indexed for MEDLINE]
	INTERLEUKIN-6 AND INTERLEUKIN-10 AS BIOMARKERS OF HEPATOCELLULAR CARCINOMA PROGRESSION: A CROSS-SECTIONAL ANALYSIS OF NUTRITIONAL, CYTOKINE AND SURVIVAL PARAMETERS. Arq Gastroenterol Faria IC, Monici LT, Pavan CR, Almeida JRS, Faria SHDM, Sevá-Pereira T. PMID: 41379186 [PubMed - indexed for MEDLINE]
	VALIDATION OF THE PAGE-B SCORE AS A PROGNOSIS OF DEVELOPMENT TO HEPATOCELLULAR CARCINOMA (HCC) IN CHRONIC HEPATITIS B, IN THE BRAZILIAN POPULATION. Arq Gastroenterol Silva ILV, Lins-Kusterer L, Silva Júnior WD, Fernandes JDC, Pacheco SR, Cunha SMCFD, Salcedo JMV, Darzé LFM, Paraná R, Schinoni MI. PMID: 41379183 [PubMed - indexed for MEDLINE]
	Determine the frequency distribution of hepatocellular carcinoma (HCC) and evaluation of viral persistence in the development of HCC among Pakistani patients. J Pak Med Assoc Resham S, Khan M, Rahman E, Adnan F, Manzoor S. PMID: 41378402 [PubMed - indexed for MEDLINE]
	Transient elastography and fibrosis-4 index as predictors of hepatocellular carcinoma in hepatitis C virus patients with sustained virological response. World J Gastroenterol da Silva PGF, Barrocas JBP, Perazzo H, Villela-Nogueira L, Peixoto HR, Pereira GHS, Braga LNP, Chinzon M, de Silva JRL, Fernandes FF, Villela-Nogueira CA. PMID: 41378329 [PubMed - indexed for MEDLINE]
	Comparison of the efficacy of laparoscopic hepatectomy and radiofrequency ablation for small hepatocellular carcinoma: A retrospective study. World J Gastroenterol Lei ZL, Tan ZL, Luo YH, Yang M, Wang JL, Qin Z, Liu YY. PMID: 41378322 [PubMed - indexed for MEDLINE]
	Development and validation of the FAAP model for prognostic stratification in HCC patients treated with TACE, sintilimab plus bevacizumab: a multicenter study. Front Immunol Ren L, Chen D, Zhang X, She S, Fei R, Cong X, Mu S, Zhou Y, Gao J, Liao W, Chen H. PMID: 41376633 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 74665

Page 1 of 3734



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy